065660.KQ
Anterogen.Co.,Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 14,080.00
+0.86%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.74x
- Price / sales
- 16.68x
- Price / cash flow
- -125.35x
Enterprise value
- Enterprise value
- KRW 96.9B
- EV / sales
- 11.58x
- EV / EBITDA
- -54.01x
- EV / EBIT
- -39.39x
- Market cap
- KRW 139.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026